Enrolling by invitationPhase 3NCT06420297
OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
Studying Prader-Willi syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Intervention
- Carbetocin(drug)
- Enrollment
- 160 enrolled
- Eligibility
- 5-30 years · All sexes
- Timeline
- 2024 – 2029
Study locations (30)
- Children's of Alabama, Birmingham, Alabama, United States
- Phoenix Children's Hospital, Phoenix, Arizona, United States
- University of California Irvine, Orange, California, United States
- Stanford University School of Medicine, Palo Alto, California, United States
- Rady Children's Hospital San Diego, San Diego, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- University of Iowa, Iowa City, Iowa, United States
- Boston Children's Hospital, Boston, Massachusetts, United States
- Children's Mercy Kansas City, Kansas City, Missouri, United States
- SSM Health/Saint Louis University, St Louis, Missouri, United States
- Maimonides Medical Center, Brooklyn, New York, United States
- Nationwide Children's Hospital, Columbus, Ohio, United States
- UPMC-Children's Hospital Pittsburgh, Pittsburgh, Pennsylvania, United States
- Vanderbilt Clinical Research Center, Nashville, Tennessee, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06420297 on ClinicalTrials.govOther trials for Prader-Willi syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07450664Observational Study of VYKAT™ XR in Patients With Prader-Willi SyndromeSoleno Therapeutics, Inc.
- ENROLLING BY INVITATIONPHASE3NCT07219485A Study of Pitolisant in Participants With Prader-Willi SyndromeHarmony Biosciences Management, Inc.
- RECRUITINGPHASE4NCT06901245Tirzepatide in PWS, HO and GNSOGrace Kim
- RECRUITINGNCT06877715Autistic Symptomatology and Sensory Profile in Children With Prader-Willi SyndromeUniversity Hospital, Toulouse
- ACTIVE NOT RECRUITINGPHASE2NCT06772597A Study of Setmelanotide in Patients With Prader-Willi SyndromeRhythm Pharmaceuticals, Inc.
- RECRUITINGPHASE3NCT06366464A Study of Pitolisant in Patients With Prader-Willi SyndromeHarmony Biosciences Management, Inc.
- ACTIVE NOT RECRUITINGPHASE3NCT06144645A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWSFoundation for Prader-Willi Research
- ACTIVE NOT RECRUITINGPHASE3NCT06173531Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeACADIA Pharmaceuticals Inc.